Important note on naming: the CJC-1295 component supplied here is the no-DAC variant (Modified GRF 1-29) with a half-life of about thirty minutes, not the long-acting DAC-conjugated form (~6 to 8 day half-life) that some researchers expect when they say "CJC-1295"
Wegovy and Zepbound, for example, cost roughly $1,000 per month before insurance, which carries strict eligibility criteria
At this time early research in general shows the plus side of these medications outweighs some potential side effects. In this The risk of diabetic retinopathy came with the results of the SUSTAIN 6 trial, the first that compared the effect of semaglutide in cardiovascular outcomes in subjects with type 2 diabetes, Fernando Gerchman, MD, PhD, professor of medicine in the Division of Endocrinology and Metabolism at the Hospital de Clnicas de Porto Alegre in Brazil and senior author of this study, told MNT
Lack of oxygen kills cells and slows down brain function and other organs